Increased Expression of Regulatory T Cells and Down-Regulatory Molecules in Lepromatous Leprosy

Carregando...
Imagem de Miniatura
Citações na Scopus
66
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC TROP MED & HYGIENE
Citação
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.86, n.5, p.878-883, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
T regulatory cells (Tregs) play an important role in the mechanism of host's failure to control pathogen dissemination in severe forms of different chronic granulomatous diseases, but their role in leprosy has not yet been elucidated; 28 newly diagnosed patients (16 patients with lepromatous leprosy and 12 patients with tuberculoid leprosy) and 6 healthy Mycobacterium leprae-exposed individuals (contacts) were studied. Tregs were quantified by flow cytometry (CD4+ CD25+ Foxp3+) in peripheral blood mononuclear cells stimulated in vitro with a M. leprae antigenic preparation and phytohemagglutinin as well as in skin lesions by immunohistochemistry. The lymphoproliferative (LPR), interleukin-10 (IL-10), and interferon-gamma (IFN-gamma) responses of the in vitro-stimulated peripheral blood mononuclear cells and the in situ expression of IL-10, transforming growth factor-beta (TGF-beta), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) were also determined. We show that M. leprae antigens induced significantly lower LPR but significantly higher Treg numbers in lepromatous than tuberculoid patients and contacts. Mitogen-induced LPR and Treg frequencies were not significantly different among the three groups. Tregs were also more frequent in situ in lepromatous patients, and this finding was paralleled by increased expression of the antiinflammatory molecules IL-10 and CTLA-4 but not TGF-beta. In lepromatous patients, Tregs were intermingled with vacuolized hystiocyte infiltrates all over the lesion, whereas in tuberculoid patients, Tregs were rare. Our results suggest that Tregs are present in increased numbers, and they may have a pathogenic role in leprosy patients harboring uncontrolled bacillary multiplication but not in those individuals capable of limiting M. leprae growth.
Palavras-chave
Referências
  1. Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x
  2. Attia EAS, 2010, INT J DERMATOL, V49, P1152, DOI 10.1111/j.1365-4632.2010.04535.x
  3. Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812
  4. Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
  5. Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08
  6. Campanelli AP, 2006, J INFECT DIS, V193, P1313, DOI 10.1086/502980
  7. Cavassani KA, 2006, J IMMUNOL, V177, P5811
  8. Engler JB, 2011, ANN RHEUM DIS, V70, P2176, DOI 10.1136/ard.2011.153619
  9. Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923
  10. Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC
  11. HAREGEWOIN A, 1985, IMMUNOL LETT, V11, P249, DOI 10.1016/0165-2478(85)90175-0
  12. Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681
  13. Ismail A, 2006, J CUTAN PATHOL, V33, P778, DOI 10.1111/j.1600-0560.2006.00531.x
  14. Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171
  15. Kuhn A, 2009, ARCH DERMATOL RES, V301, P71, DOI 10.1007/s00403-008-0891-9
  16. LONGLEY J, 1985, INT J LEPROSY, V53, P385
  17. Massone C, 2010, AM J DERMATOPATH, V32, P251, DOI 10.1097/DAD.0b013e3181b7fc56
  18. Maurya R, 2010, PARASITE IMMUNOL, V32, P479, DOI 10.1111/j.1365-3024.2010.01219.x
  19. MODLIN RL, 1986, J IMMUNOL, V137, P2831
  20. Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7
  21. Pagliari C, 2011, MICROB PATHOGENESIS, V50, P263, DOI 10.1016/j.micpath.2010.12.008
  22. Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
  23. Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785
  24. Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010
  25. Silva LCR, 2010, ARCH DERMATOL RES, V302, P255, DOI 10.1007/s00403-009-0982-2